Previous Close | 4.86 |
Open | 5.30 |
Bid | 5.00 x 1100 |
Ask | 6.29 x 800 |
Day's Range | 5.05 - 5.80 |
52 Week Range | 4.19 - 19.83 |
Volume | |
Avg. Volume | 399,095 |
Market Cap | 208.124M |
Beta (5Y Monthly) | 1.28 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.48 |
Earnings Date | Mar 07, 2022 - Mar 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 29.89 |
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 40.23% and 548.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
RADNOR, Pa., May 12, 2022--Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
RADNOR, Pa., May 10, 2022--Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)